Oscar Health, Inc. Class A (OSCR)

Oscar Health's stock price has been impacted by several events in the past six months. The stock surged around July 7, 2025, after the company announced promising Q3 earnings that exceeded market expectations. On January 5, 2026, Oscar Health's shares jumped 12.7% following an upgrade from Barclays. In mid-December 2025, Stephens & Co. initiated coverage on the stock with an "Equal-Weight" rating. New options for Oscar Health (OSCR) with a July 2026 expiration became available on November 20, 2025. Around November 26, 2025, the stock also saw a significant increase of 7.83% due to growing interest in its innovative health insurance solutions and projections of improved profitability. Additionally, the House's backing of an extension for ACA subsidies has temporarily reduced downside risk for Oscar Health. Management's plan for a disciplined 28% weighted average rate increase in 2026, coupled with AI-driven cost controls and targeted products, is positioning the company for a potential profitability inflection in 2026.

Demand for Oscar Health's products and services exhibits clear seasonality, primarily driven by the annual Open Enrollment period for health insurance, which typically runs from November 1 to December 15 in most states. For 2025 coverage, the Open Enrollment period extended to January 15, 2025. Outside of this window, enrollment is generally limited to individuals who have experienced a "qualifying life event." Additionally, Oscar Health anticipates a fourth-quarter increase in utilization of its services.

Oscar Health, Inc. is a technology-driven health insurance company founded in 2012 and headquartered in New York City, with a mission to simplify healthcare. It operates within the Life & Health Insurance sector and the Managed Health Care industry, offering individual and family plans, small group plans, and Medicare Advantage plans. The company's full-stack technology platform, +Oscar, is licensed to other healthcare providers and payers. Oscar Health distinguishes itself through a user-friendly digital interface, transparent pricing, and a focus on personalized care guidance, leveraging data and digital tools to improve health outcomes.

Oscar Health's operations are primarily focused within the United States. As of 2022, the company operated in 22 states and 607 counties. For 2025, Oscar Health plans to offer its services in 504 counties across 18 states, focusing on the Affordable Care Act (ACA) marketplace and new forms of coverage for workers and employers.

Oscar Health has maintained a positive brand reputation, emphasizing its commitment to member satisfaction and accessible healthcare. As of Q1 2024, the company reported an industry-leading Net Promoter Score (NPS) of 66 and a solid member retention rate of 82% for Open Enrollment 2024. Oscar Health is recognized for its technology-driven approach to making healthcare affordable, accessible, and engaging. A Forbes Advisor review from May 2025 highlighted Oscar's competitive bronze plan premiums and lower-than-average deductibles, along with a decent digital experience and low complaint levels for individual health plans. The company's 2024 Impact Report underscored its focus on personalized healthcare experiences tailored to unique member needs. Oscar Health also continues to advocate for innovative benefit designs and the Individual Coverage Healthcare Reimbursement Arrangement (ICHRA) to address affordability and choice in healthcare.

Oscar Health, Inc. has 594 institutional owners and shareholders holding a total of 180,788,287 shares. Major institutional owners include Vanguard Group Inc, BlackRock, Inc., T. Rowe Price Investment Management, Inc., Susquehanna International Group, Llp, and State Street Corp. Institutional ownership accounts for approximately 68.54% of the company, while individuals hold about 4.02%. Insiders own approximately 24.46% of Oscar Health.